ARM · NASDAQ-GS
Consensus is Buy across 23 analysts, with a supplied mean target of $260; the low and high targets are unavailable, so the full dispersion cannot be measured. Named targets range from New Street’s $260 to UBS analyst Timothy Arcuri’s $320, while another unnamed analyst raised a price objective to $315. Among identifiable actions, UBS is the most bullish by target and New Street is the least bullish, although neither defines the overall consensus range. Revisions were mixed over the past week: New Street upgraded Arm to Buy from Neutral, while UBS cut its target to $320 from $360. The substantive disagreement is whether AI, cloud and data-center growth can offset execution risks and an elevated valuation.